RecallDepth
Class II Terminated

Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc., Princeton, NJ 08540 NDC 0185-0022-01.

Company
Sandoz Inc
Recall Initiated
March 21, 2022
Posted
April 13, 2022
Recall Number
D-0753-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7908 bottles(790,800 extended release tablets)
Firm Location
Princeton, NJ, United States

Reason for Recall

CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.

Distribution

Nationwide

Lot / Code Info

Lot #: JX6411, JX6413, Exp. 05/2022 Lot #: KC0723,KC3303, Exp. 08/2022 Lot #: KE4348, KE7169,KE4349, Exp. 11/2022 Lot #: KL3199, KM0072,KS3939, Exp. 03/2023 Lot #: LA7704, LA7703,LA9243, Exp. 11/2023

More recalls by Sandoz Inc

View all recalls by this company →

Other recent Class II Drug recalls